Therefore, identification of the enzymes that mediate the proteolytic cleavage of TDP-43 filaments and aggregates represents an important first step that could pave the way for novel therapies to slow the spreading of pathology and progression of ALS and other TDP-43 proteinopathies. Here, TARDBP is linked to proteostasis deficiencies.